EDO-S101 for MGMT Unmethylated Glioblastoma (nGBM)

You may be eligible for inclusion in the above clinical trial, which is being conducted at the MD Anderson Cancer Center in Texas in the USA. The aim of the study is to examine the effects of the novel treatment tinostamustine in those patients with certain types of brain cancer who do not respond to alternative therapies.

If you wish to be considered for this study, you should contact your healthcare professional and they will assess your suitability and if appropriate, refer you to the centre undertaking the trial.

To take part in this trial, you will have to meet certain requirements, which include: Age ≥18 years, that you are not currently pregnant and/or breastfeeding and that you have not recently participated in a clinical trial.